# US 2023/0065544 A1 · Isophthalaminde compound and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0065544 A1
- Document ID: US20230065544A1
- Status: Published application
- Kind: A1
- Application number: 17/638,724
- Filed: 2020-08-24
- Published: 2023-03-02
- Earliest claimed: 2019-08-26
- Assignees: Metisa Biotechnology Co., Ltd
- Applicants: Metisa Biotechnology Co., Ltd
- Inventors: Lixin ZHANG; Jing ZHANG; Hongyan PEI; Jie WANG; Zhubo SHENG; Zhuo KANG
- Web page: https://patentgrep.com/patent/US20230065544A1

## CPC

- C07D 213/26: Radicals substituted by halogen atoms or nitro radicals
- A01N 37/22: the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides
- A01N 37/44: containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N 43/40: six-membered rings
- A01P 7/04: Insecticides
- A61K 31/44: Non condensed pyridines; Hydrogenated derivatives thereof
- A61P 33/00: Antiparasitic agents
- C07C 237/40: having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
- C07C 255/42: the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C 255/57: containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
- C07D 213/16: containing only one pyridine ring
- C07D 213/82: in position 3
- C07D 213/84: Nitriles
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

This disclosure provides an isophthalamide compound and use thereof, wherein the compound has a structure as shown by general formula I: the definition of each substituent in the formula is shown in the specification. The specification also discloses use thereof as an insecticide and an animal parasite control agent.

## Claims

### Claim at position 1

1-24. (canceled)

### Claim 25

An isophthalamide compound, wherein the isophthalamide compound has a structure shown by general formula I:
In the general formula I:
R1 is selected from halogen;
R2 is selected from halogen, C1-C4 halogenoalkyl, and C1-C4 halogenoalkoxy;
R3 is CF3 or CF2CF3;
R4 is selected from cyano C1-C4 alkyl;
R5 is selected from fluorine, difluoromethyl, and trifluoromethyl.

### Claim 26 (depends on 25)

The compound according to claim 25, wherein, in the formula I
R1 is bromine or iodine;
R2 is selected from bromine, iodine, trifluoromethyl, and difluoromethoxy;
R3 is CF3 or CF2CF3;
R4 is selected from CH2CN, CH2CH2CN, CH2CH2CH2CN, CH2CH2CH2CH2CN, CH(CH3)CN, CH(CH2CH3)CN, CH(CH2CH2CH3)CN, C(CH3)(CH3)CN, and C(CH3)(CH2CH3)CN;
R5 is selected from fluorine, difluoromethyl, and trifluoromethyl.

### Claim 27 (depends on 25)

The isophthalamide compound according to claim 25, wherein the isophthalamide compound is selected from:
compounds in Table 1, wherein the compounds in Table 1 have a structure shown by the general formula I and R1, R2, R3, R4, and R5 are as shown in Table 1:
TABLE 1
Compound
No.
R1
R2
R3
R4
R5
1
Br
Br
CF3
CH2CN
F
2
Br
Br
CF3
CH2CH2CN
F
3
Br
Br
CF3
CH2CH2CH2CN
F
4
Br
Br
CF3
CH2CH2CH2CH2CN
F
5
Br
I
CF3
CH2CN
F
6
Br
I
CF3
CH2CH2CN
F
7
Br
I
CF3
CH2CH2CH2CN
F
8
Br
I
CF3
CH2CH2CH2CH2CN
F
9
Br
CF3
CF3
CH2CN
F
10
Br
CF3
CF3
CH2CH2CN
F
11
Br
CF3
CF3
CH2CH2CH2CN
F
12
Br
CF3
CF3
CH2CH2CH2CH2CN
F
13
I
CF3
CF3
CH2CN
F
14
I
CF3
CF3
CH2CH2CN
F
15
I
CF3
CF3
CH2CH2CH2CN
F
16
I
CF3
CF3
CH2CH2CH2CH2CN
F
17
Br
Br
CF3
CH2CN
CF3
18
Br
Br
CF3
CH2CH2CN
CF3
19
Br
Br
CF3
CH2CH2CH2CN
CF3
20
Br
Br
CF3
CH2CH2CH2CH2CN
CF3
21
Br
I
CF3
CH2CN
CF3
22
Br
I
CF3
CH2CH2CN
CF3
23
Br
I
CF3
CH2CH2CH2CN
CF3
24
Br
I
CF3
CH2CH2CH2CH2CN
CF3
25
Br
CF3
CF3
CH2CN
CF3
26
Br
CF3
CF3
CH2CH2CN
CF3
27
Br
CF3
CF3
CH2CH2CH2CN
CF3
28
Br
CF3
CF3
CH2CH2CH2CH2CN
CF3
29
I
CF3
CF3
CH2CN
CF3
30
I
CF3
CF3
CH2CH2CN
CF3
31
I
CF3
CF3
CH2CH2CH2CN
CF3
32
I
CF3
CF3
CH2CH2CH2CH2CN
CF3
33
Br
Br
CF3
CH2CN
CHF2
34
Br
Br
CF3
CH2CH2CN
CHF2
35
Br
Br
CF3
CH2CH2CH2CN
CHF2
36
Br
Br
CF3
CH2CH2CH2CH2CN
CHF2
37
Br
I
CF3
CH2CN
CHF2
38
Br
I
CF3
CH2CH2CN
CHF2
39
Br
I
CF3
CH2CH2CH2CN
CHF2
40
Br
I
CF3
CH2CH2CH2CH2CN
CHF2
41
Br
CF3
CF3
CH2CN
CHF2
42
Br
CF3
CF3
CH2CH2CN
CHF2
43
Br
CF3
CF3
CH2CH2CH2CN
CHF2
44
Br
CF3
CF3
CH2CH2CH2CH2CN
CHF2
45
I
CF3
CF3
CH2CN
CHF2
46
I
CF3
CF3
CH2CH2CN
CHF2
47
I
CF3
CF3
CH2CH2CH2CN
CHF2
48
I
CF3
CF3
CH2CH2CH2CH2CN
CHF2
49
Br
Br
CF2CF3
CH2CN
F
50
Br
Br
CF2CF3
CH2CH2CN
F
51
Br
Br
CF2CF3
CH2CH2CH2CN
F
52
Br
Br
CF2CF3
CH2CH2CH2CH2CN
F
53
Br
I
CF2CF3
CH2CN
F
54
Br
I
CF2CF3
CH2CH2CN
F
55
Br
I
CF2CF3
CH2CH2CH2CN
F
56
Br
I
CF2CF3
CH2CH2CH2CH2CN
F
57
Br
CF3
CF2CF3
CH2CN
F
58
Br
CF3
CF2CF3
CH2CH2CN
F
59
Br
CF3
CF2CF3
CH2CH2CH2CN
F
60
Br
CF3
CF2CF3
CH2CH2CH2CH2CN
F
61
I
CF3
CF2CF3
CH2CN
F
62
I
CF3
CF2CF3
CH2CH2CN
F
63
I
CF3
CF2CF3
CH2CH2CH2CN
F
64
I
CF3
CF2CF3
CH2CH2CH2CH2CN
F
65
Br
Br
CF2CF3
CH2CN
CF3
66
Br
Br
CF2CF3
CH2CH2CN
CF3
67
Br
Br
CF2CF3
CH2CH2CH2CN
CF3
68
Br
Br
CF2CF3
CH2CH2CH2CH2CN
CF3
69
Br
I
CF2CF3
CH2CN
CF3
70
Br
I
CF2CF3
CH2CH2CN
CF3
71
Br
I
CF2CF3
CH2CH2CH2CN
CF3
72
Br
I
CF2CF3
CH2CH2CH2CH2CN
CF3
73
Br
CF3
CF2CF3
CH2CN
CF3
74
Br
CF3
CF2CF3
CH2CH2CN
CF3
75
Br
CF3
CF2CF3
CH2CH2CH2CN
CF3
76
Br
CF3
CF2CF3
CH2CH2CH2CH2CN
CF3
77
I
CF3
CF2CF3
CH2CN
CF3
78
I
CF3
CF2CF3
CH2CH2CN
CF3
79
I
CF3
CF2CF3
CH2CH2CH2CN
CF3
80
I
CF3
CF2CF3
CH2CH2CH2CH2CN
CF3
81
Br
Br
CF2CF3
CH2CN
CHF2
82
Br
Br
CF2CF3
CH2CH2CN
CHF2
83
Br
Br
CF2CF3
CH2CH2CH2CN
CHF2
84
Br
Br
CF2CF3
CH2CH2CH2CH2CN
CHF2
85
Br
I
CF2CF3
CH2CN
CHF2
86
Br
I
CF2CF3
CH2CH2CN
CHF2
87
Br
I
CF2CF3
CH2CH2CH2CN
CHF2
88
Br
I
CF2CF3
CH2CH2CH2CH2CN
CHF2
89
Br
CF3
CF2CF3
CH2CN
CHF2
90
Br
CF3
CF2CF3
CH2CH2CN
CHF2
91
Br
CF3
CF2CF3
CH2CH2CH2CN
CHF2
92
Br
CF3
CF2CF3
CH2CH2CH2CH2CN
CHF2
93
I
CF3
CF2CF3
CH2CN
CHF2
94
I
CF3
CF2CF3
CH2CH2CN
CHF2
95
I
CF3
CF2CF3
CH2CH2CH2CN
CHF2
96
I
CF3
CF2CF3
CH2CH2CH2CH2CN
CHF2

### Claim 28 (depends on 25)

The isophthalamide compound according to claim 25, wherein the isophthalamide compound is selected from:
compounds in Table 2, wherein the compounds in Table 2 have a structure shown by the general formula I and R1, R2, R3, R4 and R5 are as shown in Table 2:
TABLE 2
Compound
No.
R1
R2
R3
R4
R5
1
Br
Br
CF3
CH2CN
F
2
Br
Br
CF3
CH2CH2CN
F
3
Br
Br
CF3
CH2CH2CH2CN
F
4
Br
Br
CF3
CH2CH2CH2CH2CN
F
5
Br
I
CF3
CH2CN
F
6
Br
I
CF3
CH2CH2CN
F
7
Br
I
CF3
CH2CH2CH2CN
F
8
Br
I
CF3
CH2CH2CH2CH2CN
F
9
Br
CF3
CF3
CH2CN
F
10
Br
CF3
CF3
CH2CH2CN
F
11
Br
CF3
CF3
CH2CH2CH2CN
F
12
Br
CF3
CF3
CH2CH2CH2CH2CN
F
13
I
CF3
CF3
CH2CN
F
14
I
CF3
CF3
CH2CH2CN
F
15
I
CF3
CF3
CH2CH2CH2CN
F
16
I
CF3
CF3
CH2CH2CH2CH2CN
F
17
Br
Br
CF3
CH2CN
CF3
18
Br
Br
CF3
CH2CH2CN
CF3
19
Br
Br
CF3
CH2CH2CH2CN
CF3
20
Br
Br
CF3
CH2CH2CH2CH2CN
CF3
21
Br
I
CF3
CH2CN
CF3
22
Br
I
CF3
CH2CH2CN
CF3
23
Br
I
CF3
CH2CH2CH2CN
CF3
24
Br
I
CF3
CH2CH2CH2CH2CN
CF3
25
Br
CF3
CF3
CH2CN
CF3
26
Br
CF3
CF3
CH2CH2CN
CF3
27
Br
CF3
CF3
CH2CH2CH2CN
CF3
28
Br
CF3
CF3
CH2CH2CH2CH2CN
CF3
29
I
CF3
CF3
CH2CN
CF3
30
I
CF3
CF3
CH2CH2CN
CF3
31
I
CF3
CF3
CH2CH2CH2CN
CF3
32
I
CF3
CF3
CH2CH2CH2CH2CN
CF3

### Claim 29 (depends on 25)

An intermediate compound for preparing the isophthalamide compound according to claim 25, wherein the intermediate compound is represented by general formula II:
In the general formula II:
R1 is selected from halogen;
R2 is selected from halogen, C1-C4 halogenoalkyl, and C1-C4 halogenoalkoxy;
R3 is CF3 or CF2CF3;
R4 is selected from cyano C1-C4 alkyl.

### Claim 30 (depends on 29)

The intermediate compound according to claim 29, wherein, in the general formula II, R1 is bromine or iodine;
R2 is selected from bromine, iodine, trifluoromethyl, and difluoromethoxy;
R3 is CF3 or CF2CF3;
R4 is selected from CH2CN, CH2CH2CN, CH2CH2CH2CN, CH2CH2CH2CH2CN, CH(CH3)CN, CH(CH2CH3)CN, CH(CH2CH2CH3)CN, C(CH3)(CH3)CN, and C(CH3)(CH2CH3)CN.

### Claim 31 (depends on 30)

The intermediate compound according to claim 30, wherein, the intermediate compound is selected from:
compounds in Table 3, wherein the compounds of Table 3 have a structure shown by the general formula II and R1, R2, R3, and R4 are as shown in Table 3:
TABLE 3
No.
R1
R2
R3
R4
II.1
Br
Br
CF3
CH2CN
II.2
Br
Br
CF3
CH2CH2CN
II.3
Br
Br
CF3
CH2CH2CH2CN
II.4
Br
Br
CF3
CH2CH2CH2CH2CN
II.5
Br
I
CF3
CH2CN
II.6
Br
I
CF3
CH2CH2CN
II.7
Br
I
CF3
CH2CH2CH2CN
II.8
Br
I
CF3
CH2CH2CH2CH2CN
II.9
Br
CF3
CF3
CH2CN
II.10
Br
CF3
CF3
CH2CH2CN
II.11
Br
CF3
CF3
CH2CH2CH2CN
II.12
Br
CF3
CF3
CH2CH2CH2CH2CN
II.13
I
CF3
CF3
CH2CN
II.14
I
CF3
CF3
CH2CH2CN
II.15
I
CF3
CF3
CH2CH2CH2CN
II.16
I
CF3
CF3
CH2CH2CH2CH2CN
II.17
Br
Br
CF2CF3
CH2CN
II.18
Br
Br
CF2CF3
CH2CH2CN
II.19
Br
Br
CF2CF3
CH2CH2CH2CN
II.20
Br
Br
CF2CF3
CH2CH2CH2CH2CN
II.21
Br
I
CF2CF3
CH2CN
II.22
Br
I
CF2CF3
CH2CH2CN
II.23
Br
I
CF2CF3
CH2CH2CH2CN
II.24
Br
I
CF2CF3
CH2CH2CH2CH2CN
II.25
Br
CF3
CF2CF3
CH2CN
II.26
Br
CF3
CF2CF3
CH2CH2CN
II.27
Br
CF3
CF2CF3
CH2CH2CH2CN
II.28
Br
CF3
CF2CF3
CH2CH2CH2CH2CN
II.29
I
CF3
CF2CF3
CH2CN
II.30
I
CF3
CF2CF3
CH2CH2CN
II.31
I
CF3
CF2CF3
CH2CH2CH2CN
II.32
I
CF3
CF2CF3
CH2CH2CH2CH2CN

### Claim 32 (depends on 25)

An intermediate compound for preparing the isophthalamide compound according to claim 25, wherein the compound is represented by general formula III:
In the general formula III:
R4 is selected from cyano C1-C4 alkyl;
R5 is selected from fluorine, difluoromethyl, and trifluoromethyl;
L is selected from halogen and hydroxyl.

### Claim 33 (depends on 32)

The intermediate compound according to claim 32, wherein, in the general formula III,
R4 is selected from CH2CN, CH2CH2CN, CH2CH2CH2CN, CH2CH2CH2CH2CN, CH(CH3)CN, CH(CH2CH3)CN, CH(CH2CH2CH3)CN, C(CH3)(CH3)CN, and C(CH3)(CH2CH3)CN;
R5 is selected from fluorine, difluoromethyl, and trifluoromethyl;
L is selected from halogen and hydroxyl.

### Claim 34 (depends on 33)

The intermediate compound according to claim 33, wherein, the intermediate compound is selected from:
compounds in Table 4, wherein the compounds of Table 4 have a structure shown by the general formula III and R4, R5, and L are as shown in Table 4:
TABLE 4
No.
R4
R5
L
III.1
CH2CN
F
Cl
III.2
CH2CH2CN
F
Cl
III.3
CH2CH2CH2CN
F
Cl
III.4
CH2CH2CH2CH2CN
F
Cl
III.5
CH2CN
F
OH
III.6
CH2CH2CN
F
OH
III.7
CH2CH2CH2CN
F
OH
III.8
CH2CH2CH2CH2CN
F
OH
III.9
CH2CN
CF3
Cl
III.10
CH2CH2CN
CF3
Cl
III.11
CH2CH2CH2CN
CF3
Cl
III.12
CH2CH2CH2CH2CN
CF3
Cl
III.13
CH2CN
CF3
OH
III.14
CH2CH2CN
CF3
OH
III.15
CH2CH2CH2CN
CF3
OH
III.16
CH2CH2CH2CH2CN
CF3
OH

### Claim 35 (depends on 25)

Use of the isophthalamide compound according to claim 25 for preparing an insecticide.

### Claim 36 (depends on 35)

The use according to claim 35, wherein the insecticide is used to control one or more of Leucania separata, Plutella xylostella, and Chilo suppressalis.

### Claim 37 (depends on 25)

An insecticide formulation, wherein the insecticide formulation comprises the isophthalamide compound according to claim 25 as an active component, and also one or more adjuvants; and optionally, the amount of the isophthalamide compound according to claim 25 in the insecticide formulation is 0.1% to 99% by weight, further optionally, 0.5% to 90% by weight.

### Claim 38 (depends on 25)

An insecticide composition, comprising a mixture of the isophthalamide compound according to claim 25 and another active compound, wherein the another active compound is one or more selected from an insecticide, a poison bait, a disinfectant, an acaricide, a nematicide, a fungicide, a growth regulator, and a herbicide.

### Claim 39 (depends on 25)

A method for controlling an agricultural or forestry pest, comprising applying an effective dose of a material to the pest to be controlled or a growth medium thereof, wherein the material is one or more selected from the following group:
the isophthalamide compound according to claim 25;
the insecticide formulation; and
the insecticide composition.

### Claim 40 (depends on 25)

Use of the isophthalamide compound according to claim 25 for preparing an animal parasite control agent.

### Claim 41 (depends on 40)

The use according to claim 40, wherein the animal parasite control agent is used to control one or more of cat fleas and American dog ticks.

### Claim 42 (depends on 1, 25)

An animal parasite control agent, comprising the isophthalamide compound according to claim 25 as an active component, and also one or more adjuvants; and optionally, the amount of the isophthalamide compound according to claim 1 in the animal parasite control agent is 1% to 80% by weight.

### Claim 43 (depends on 25)

An animal parasite control composition, comprising a mixture of the isophthalamide compound according to claim 25 and another active animal parasite control compound, wherein the another active animal parasite control compound is one or more selected from an acaricide, an insecticide, a parasiticide, and antimalarial agent.

### Claim 44 (depends on 25)

A method for controlling an animal parasite, comprising the step of applying an effective dose of a material to the animal parasite to be controlled or a growth medium thereof, wherein the material is one or more selected from the following group:
the isophthalamide according to claim 25;
the animal parasite control agent; and
the animal parasite control composition.
